00955nas a2200349   4500000000100000000000100001000000100002008004100003653001100044653004400055653003700099653001600136653002400152653002600176653002800202653004500230653001900275653002600294653001300320653001300333100001700346700001400363700001200377700001300389700001300402700001900415245012300434250001500557300001200572490000700584020001400591       2023                            d10aHumans10a*Anti-Arrhythmia Agents/therapeutic use10a*Anticonvulsants/therapeutic use10aElectronics10aPrimary health care10aRetrospective Studies10a*Neoplasms/drug therapy10a*Sodium Channel Blockers/therapeutic use10aBreast tumours10aClinical pharmacology10aepilepsy10aOncology1 aC. Fairhurst1 aF. Martin1 aI. Watt1 aM. Bland1 aT. Doran1 aW. Brackenbury00aSodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data  a2023/02/04  ae0643760 v13  a2044-6055